- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 295/195 - Radicaux dérivés d'analogues azotés d'acides carboxyliques
Détention brevets de la classe C07D 295/195
Brevets de cette classe: 88
Historique des publications depuis 10 ans
|
9
|
9
|
10
|
8
|
9
|
2
|
5
|
4
|
7
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The General Hospital Corporation | 4637 |
6 |
| Reata Pharmaceuticals Holdings, LLC | 46 |
6 |
| Massachusetts Institute of Technology | 9903 |
5 |
| The Broad Institute, Inc. | 1703 |
5 |
| Concentric Analgesics, Inc. | 24 |
4 |
| Syngenta Participations AG | 3039 |
3 |
| President and Fellows of Harvard College | 5904 |
3 |
| Rhizen Pharmaceuticals AG | 56 |
3 |
| Bristol-myers Squibb Company | 4886 |
2 |
| Bayer Cropscience AG | 2143 |
2 |
| Ricoh Company, Ltd. | 13202 |
2 |
| University of Florida Research Foundation, Inc. | 3951 |
2 |
| Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 70 |
2 |
| Northeastern University | 1132 |
2 |
| Novira Therapeutics, Inc. | 32 |
2 |
| Oryzon Genomics S.A. | 105 |
2 |
| Recordati Industria Chimica e Farmaceutica S.p.A. | 56 |
2 |
| Corteva Agriscience LLC | 2677 |
2 |
| Wisorig Technologies Pte. Limited | 10 |
2 |
| Boehringer Ingelheim International GmbH | 4762 |
1 |
| Autres propriétaires | 30 |